Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Roblox
RBLX
|
+$524M |
| 2 |
JPMorgan Chase
JPM
|
+$515M |
| 3 |
Amazon
AMZN
|
+$505M |
| 4 |
AT&T
T
|
+$450M |
| 5 |
Coinbase
COIN
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$836M |
| 2 |
Advanced Micro Devices
AMD
|
+$706M |
| 3 |
Adobe
ADBE
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$508M |
| 5 |
Nike
NKE
|
+$442M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.47% |
| 2 | Technology | 17.63% |
| 3 | Consumer Staples | 10.26% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Financials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
NetEase
NTES
$85.3B
| $478K | ﹤0.01% |
4,700
-686,516
| -99% | -$69.7M |
|
3102
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.39B
| $475K | ﹤0.01% |
+6,800
| New | +$461K |
|
3103
Birks Group
BGI
$9.46M
| $474K | ﹤0.01% |
97,806
+14,010
| +17% | +$58K |
|
|
REVG
3104
DELISTED
REV Group
REVG
| $474K | ﹤0.01% |
33,500
-65,500
| -66% | -$1.04M |
|
|
STAB
3105
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
| $474K | ﹤0.01% |
206,035
+91,837
| +80% | +$271K |
|
3106
Minerva Neurosciences
NERV
$185M
| $473K | ﹤0.01% |
73,888
-20,377
| -22% | -$192K |
|
|
EAR
3107
DELISTED
Eargo, Inc. Common Stock
EAR
| $471K | ﹤0.01% |
+4,620
| New | +$601K |
|
3108
iShares US Consumer Discretionary ETF
IYC
$1.17B
| $470K | ﹤0.01% |
5,600
-300
| -5% | -$24.8K |
|
|
MOR
3109
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $469K | ﹤0.01% |
49,800
-1,820
| -4% | -$19.3K |
|
3110
Alerus Financial
ALRS
$831M
| $468K | ﹤0.01% |
+16,000
| New | +$502K |
|
3111
VanEck Agribusiness ETF
MOO
$972M
| $468K | ﹤0.01% |
4,900
+2,400
| +96% | +$226K |
|
3112
Biglari Holdings Class B
BH
$1.25B
| $467K | ﹤0.01% |
3,276
-688
| -17% | -$107K |
|
|
ZSTK
3113
ZeroStack Corp
ZSTK
$3.69M
| $467K | ﹤0.01% |
+336
| New | +$921K |
|
3114
Armata Pharmaceuticals
ARMP
$167M
| $465K | ﹤0.01% |
84,796
-21,296
| -20% | -$89K |
|
3115
iShares International Select Dividend ETF
IDV
$8.45B
| $461K | ﹤0.01% |
14,800
-37,100
| -71% | -$1.15M |
|
3116
iShares US Medical Devices ETF
IHI
$3.13B
| $461K | ﹤0.01% |
7,000
-2,700
| -28% | -$173K |
|
3117
First Western Financial
MYFW
$304M
| $461K | ﹤0.01% |
+15,200
| New | +$455K |
|
3118
SkyWater Technology
SKYT
| $461K | ﹤0.01% |
+28,401
| New | +$636K |
|
3119
Erie Indemnity
ERIE
$12.7B
| $457K | ﹤0.01% |
+2,371
| New | +$476K |
|
3120
Dogness International Corp
DOGZ
$12.8M
| $455K | ﹤0.01% |
2,707
+1,892
| +232% | +$177K |
|
3121
Mirum Pharmaceuticals
MIRM
$6.46B
| $453K | ﹤0.01% |
28,400
-6,900
| -20% | -$107K |
|
3122
Fluence Energy
FLNC
$1.85B
| $452K | ﹤0.01% |
+12,700
| New | +$433K |
|
|
MYND
3123
Mynd.ai
MYND
$18M
| $451K | ﹤0.01% |
22,761
-990
| -4% | -$23.7K |
|
|
OYST
3124
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $451K | ﹤0.01% |
24,700
-87,600
| -78% | -$1.11M |
|
3125
Aethlon Medical
AEMD
$1.75M
| $450K | ﹤0.01% |
303
+240
| +381% | +$547K |
|
Similar funds
Renaissance Technologies's Q4 2021 Portfolio in Review
As of Q4 2021, Renaissance Technologies held 4,407 positions worth $80.4B, up 3.8% from $77.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2021 filing shows 984 new, 1,222 increased, 1,628 reduced and 545 closed positions. Its largest new stake was Amazon: 2,953,100 shares worth $492M. The largest sale was NVIDIA, an estimated $836M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Staples.
- Renaissance Technologies's largest Q4 2021 buy was Amazon: 2,953,100 shares worth $492M.
- Renaissance Technologies added most to Roblox in Q4 2021, an estimated $524M increase.
- Renaissance Technologies's biggest Q4 2021 reduction was NVIDIA, cutting an estimated $836M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q4 2021, selling an estimated $706M.
- Renaissance Technologies's ten largest holdings make up 12% of its $80.4B portfolio in Q4 2021.
- Renaissance Technologies opened 984 new positions and closed 545 in Q4 2021.
- Renaissance Technologies's portfolio value rose 3.8% quarter-over-quarter to $80.4B.
Based on Renaissance Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.